• O Habler, M Kleen, B Zwissler, R Pusch, M Welte, C Vogelmeier, B Kempter, F Krombach, and K Messmer.
• Institute for Surgical Research, Ludwig-Maximilians-University, Munich, Germany.
• Intensive Care Med. 1996 May 1;22(5):426-33.

ObjectiveTo study the potential side effects and toxicity of inhaling prostacyclin (PGI2) aerosol for 8 h.DesignIn a prospective, randomized study 14 healthy lambs received either PGI2 (n = 7) or 0.9% NaCl (n = 7) as an aerosol for 8 h.SettingInstitute for Surgical Research of the Ludwig-Maximilians-University of Munich.InterventionsAll animals were studied under general anesthesia in a prone position. They were first intubated endotracheally and later tracheotomized. PGI2 solution (median dose 28 ng/kg per min) or 0.9% NaCl was administered with a jet nebulizer (delivery rate 4-10 ml/h; mass median diameter of aerosol particles 3.1 microns). Bronchoalveolar lavage was performed before and after the inhalation period to collect epithelial lining fluid of alveoli.Measurements And ResultsHemodynamic and respiratory parameters, systemic resorption (plasma levels of 6-keto-prostaglandin-F 1 alpha), in vitro bleeding time, collagen-induced platelet aggregation and global biochemical and cellular composition of the epithelial lining fluid were examined in order to assess the side effects and signs of acute pulmonary toxicity induced by inhaled PGI2. No statistically significant differences were found between the PGI2 and the control groups for any of the parameters examined.ConclusionInhalation of PGI2 (28 ng/kg per min) over a period of 8 h in healthy lambs does not produce major side effects or acute pulmonary toxicity.

23 keywords...

hide…